You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 5, May 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE 94TH ANNUAL MEETING OF THE WESTERN SURGICAL ASSOCIATION, DEARBORN, MICH, NOV 16-19, 1986-Part I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (47)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pelvic and Sacropelvic Exenteration for Locally Advanced or Recurrent Anorectal Cancer

Nathan W. Pearlman, MD; Robert E. Donohue, MD; Gregory V. Stiegmann, MD; Dennis J. Ahnen, MD; Scott M. Sedlacek, MD; Thomas J. Braun, MD

Arch Surg. 1987;122(5):537-541.


Abstract

• Postirradiation "fixed" anorectal tumors are often considered incurable. Since 1980, we have carried out 12 pelvic and seven sacropelvic exenterations for this problem (adenocarcinoma, 18; squamous cancer, one). Nine tumors were primary; ten were recurrent (five after an anterior resection and five after an abdominoperineal resection). Prior irradiation ranged from 3000 to 12000 rad (30 to 120 Gy). Four patients had synchronous distant metastases; three died of disease (one with local recurrence), and the fourth patient has been living with disease (distant metastasis). Fifteen patients (four with B2 tumors and 11 with Astler-Coller C2 disease) had no extrapelvic disease. One patient died of postoperative complications; two others died free of disease. Three of the 15 patients died of disease (all with local recurrence), and one has been living with disease (local recurrence). Eight (53%) of 15 patients have been living free of disease 12+ to 53+ months. The results suggest that many patients with fixed postirradiation anorectal tumors may be salvaged by aggressive surgery.

(Arch Surg 1987;122:537-541)



Author Affiliations

From the Departments of Surgery (Drs Pearlman and Stiegmann), Urology (Dr Donohue), and Medicine (Drs Ahnen, Sedlacek, and Braun), Denver Veterans Administration Medical Center and University of Colorado Health Sciences Center.


Footnotes

Accepted for publication Jan 9, 1987.

Read before the 94th Annual Meeting of the Western Surgical Association, Dearborn, Mich, Nov 17, 1986.

Reprint requests to University Hospital, 4200 E Ninth Ave, Denver, CO 80262 (Dr Pearlman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intraoperative Gamma Detection Probe With Presurgical Antibody Imaging in Colon Cancer
Kuhn et al.
Arch Surg 1991;126:1398-1403.
ABSTRACT  

Radiation Treatment Technique and Surgical Results
PIETERS
Arch Surg 1988;123:663-663.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.